Dan Zandberg
Clinical trials sponsored by Dan Zandberg, explained in plain language.
-
New pill aims to boost power of cancer immunotherapy
Disease control OngoingThis study is testing a new oral drug, ARRY-614, to see if it can make standard immunotherapy drugs (nivolumab and ipilimumab) work better for people with advanced cancers. The first part checks the safety and best dose. The second part will see how well the combinations work to …
Phase: PHASE1, PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Triple-Threat attack on HPV-Linked throat cancer enters testing
Disease control OngoingThis study is testing whether adding a vaccine that targets the HPV virus to standard cancer treatments (chemotherapy, radiation, and an immunotherapy drug) can better control a specific type of throat cancer. It is for adults newly diagnosed with intermediate-risk, HPV-16 positi…
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC